Glutamatergic agents show promise for mood and anxiety disorders

(European College of Neuropsychopharmacology) Depression is one of the leading causes of disability worldwide. New research suggests that targeting the glutamergic system may represent an exciting new avenue for treating mood and anxiety disorders.